Corry Wang
corrywang.bsky.social
Corry Wang
@corrywang.bsky.social
Compute @ Anthropic | Formerly AI strategy @ Google and tech equity research @ Bernstein Research
4/ The one difference - all of the checks now have an extra zero (or two)

“Even young PhDs could pull a half million dollars a year”

Ilya was offered “nearly $2 million for the first year” in 2016

Some things do change!
November 11, 2025 at 4:43 PM
3/ Another thing that remains unchanged after a decade and a half - Mark Zuckerberg is extremely uninterested in AI safety, ie why DeepMind refused to sell out to Facebook
November 11, 2025 at 4:43 PM
2/ It is uncanny how much Meta’s efforts in the last year have just been a rerun of Mark’s original effort to build FAIR by hiring Yann Lecun back in 2013

- Invitations to 1-on-1 dinners with Mark

- A desk next to Mark at the office

- “Intelligent agents” booking airline tickets

- “Open source”
November 11, 2025 at 4:43 PM
1/4 If I had a nickel for every time Mark Zuckerberg blew a few billion dollars trying to hire a team of star researchers to build a second place frontier AI research lab, I’d have two nickels. Which isn’t a lot, but it’s weird that it happened twice
November 11, 2025 at 4:43 PM
10/ Page 72 literally mentions Andrew Ng showing a literal line graph to Larry Page in 2010 charting how multimodal ML performance would consistently improve with the application of more training data

But the book never *quite* brings it all together
November 10, 2025 at 5:07 AM
9/ Page 70 mentions an eyebrow-raising anecdote about how one of Geoff Hinton's grad students discovered at Google in 2011 that training a speech model with 2000 hours of data instead of 12 hours would miraculously improve error rates
November 10, 2025 at 5:07 AM
8/ The result is that the most uncanny part of reading Genius Makers is when you see the ghost of scaling laws looming on the edges

On Page 50, the book mentions Terry Sejnowski's 1987 NETtalk paper, which arguably plotted out the world's first log-linear AI scaling law
November 10, 2025 at 5:07 AM
6/ Today, I think it's probably fair to say frontier AI research is on the cusp of becoming a "normal science" for the first time, as the field has coalesced around the scaling laws paradigm that ML performance can improve predictably with the application of more compute
November 10, 2025 at 5:07 AM
3/ The result? The book spends hundreds of pages talking about: AlphaGo, GANs, LSTMs, RL agents playing DOTA...

Zero mentions of: GPT-2

In fact, there's only a *single* mention of the word "transformer" in the entire 300 page body of the book (a one-off reference to BERT)
November 10, 2025 at 5:07 AM
1/ Last week I finally got around to reading Genius Makers - this was Cade Metz's 2021 book on the history of ML

It was really fascinating, but in the same way you'd be fascinated reading a history of Newtonian physics published 3 months before Einstein invented relativity
November 10, 2025 at 5:07 AM
From 1840 to 1850, private Britons cumulatively invested 40% of British GDP into the country’s first rail network. For reference, the equivalent today would be the tech industry spending like, $10 trillion dollars on a single thing

Anyways it’s confirmed, guess we’re all doing this again guys
October 8, 2025 at 10:07 PM
I don't think Americans realize that outside the US, you can now just buy Ozempic online for $150/month. This will ultimately fall to <$50/month

This actually might've ended up as the important thing in global society in the 2020s, it weren't for the whole, yknow, AI thing
August 3, 2025 at 2:49 PM
There's a famous anecdote about the invention of the cellphone: in 1981 McKinsey estimated it'd have a TAM of <1M people, so AT&T exited the market

Turns out this anecdote is made up. AT&T's marketing team did claim this, but the engineers just ignored them and launched anyways
July 13, 2025 at 3:22 AM
I sometimes wonder these days what % of equity research is just written by ChatGPT. But then I see UBS publish a paragraph like this and realize I'm still getting 100% authentic human content
July 6, 2025 at 11:50 PM
It's quite striking that despite everything that's happened in AI over the last 3 years, the world is still spending *less* capex building semiconductor foundries today than in 2022

All of AI is still small enough to be washed away by consumers buying -10% fewer Android phones
June 21, 2025 at 3:20 PM
Of course, the big thesis for NVIDIA in 2016 was that "virtual reality is finally going to take off"

Meanwhile, AI accelerator revenues were forecasted to hit a whole... $1B in 2018. (Today, that business is runrating at $160B annualized)
June 3, 2025 at 2:03 PM
When Goldman Sachs initiated on NVIDIA in 2016, there was general amazement that any semiconductor company could actually grow revenues sustainably
June 3, 2025 at 2:03 PM
The top 2 Korean battery makers (LG and Samsung) have now burned nearly $10B of cash since mid-2022, just as CATL has flipped to $8B+ in annualized profits

Another 5 years of this, and the ex-Chinese battery industry is going to cease to exist
April 24, 2025 at 8:12 PM
I used to cover electric vehicle stocks until I joined Google in 2020

When I left, China, Korea, and the US (via Tesla’s Panasonic JV) were all roughly equal-sized in the battery market

Fast forward to last quarter, China just crossed 50% global market share
April 24, 2025 at 8:12 PM
It’s kind of wild how much China has run away with the electric vehicle battery market in the last 5 years

The largest Chinese battery maker CATL now controls 37% of global industry sales, and 90%+ of industry profits (ex-BYD)
April 24, 2025 at 8:12 PM
6/ But what’s equally interesting is what happened next

Pfizer pulled the plug in 1991, and Novo Nordisk (the future makers of Ozempic) immediately bought out the Habener patents in 1992
April 23, 2025 at 3:49 PM
4/ 1988, Pfizer agrees to fund MetaBio’s GLP-1 research program for $30M, in exchange for being its sole licensee

In 1990, MetaBio demonstrates GLP-1 efficacy in human trials for the first time

In 1991, Pfizer abruptly terminates the project!
April 23, 2025 at 3:49 PM
3/ MetaBio was founded in 1987. That was the year Joel Habener first reported GLP-1’s ability to stimulate glucose-dependent insulin secretion - in retrospect, the moment of “discovery” for GLP-1s

MetaBio became the first company in the world to license Habener’s GLP-1 patents
April 23, 2025 at 3:49 PM
1/ Was this the biggest miss in the history of pharma? Apparently in 1990, Pfizer preemptively abandoned development of the first GLP1 drugs

Ozempic, Zepbound, Wegovy, Mounjaro, etc. were doing $60B+ in runrate revenues at the end of last year. None are made by Pfizer
April 23, 2025 at 3:49 PM
I did not know this - the failed first attempt to build the Panama Canal in the 1880s cost 10% of France’s GDP

For reference, that would be equivalent to a single startup raising about $300B today
April 22, 2025 at 7:54 PM